In support of APP glycosylation as a risk factor for disease, synthesis and glycosylation of AGP, haptoglobin, and transferrin are associated with a number of chronic diseases such as pancreatitis, rheumatoid arthritis, diabetes, and inflammatory lung conditions [52–54]. This evidence concerns the gene TF and diabetes mellitus.